The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
// Fengli Lv 1, * , Suling Chen 2, * , Lina Wang 3, * , Ronghuan Jiang 4 , Hongjun Tian 3 , Jie Li 3 , Yudong Yao 5 and Chuanjun Zhuo 2, 3 1 The department of rehabilition, The Second Affiliated Hosptial of Tianjin Medical University, Tianjin, China 2 Department of Psychiatry, Wenzhou Seventh People’s Hospital, Wenzhou, Zhejiang, China 3 Department of Psychiatry, Tianjin Anding Hospital, Tianjin Mental Health Center, Tianjin, China 4 Department of Psychological Medicine, Chinese People’s Liberation Army, General Hospital, Chinese People’s Liberation Army Medical School, Beijing, China 5 Department of Pharmacology and Physiology, SUNY Downstate Medical Center, Brooklyn, NY, USA * These authors contributed equally to this work Correspondence to: Chuanjun Zhuo, email: chuanjunzhuotjmh@163.com Yudong Yao, email: zhongbaoliangwang@yeah.net Jie Li, email: tjlijie3827@163.com Keywords: microbiota, brain-gut axis, psychiatric disorders, schizophrenia, depression Received: June 15, 2017 Accepted: August 26, 2017 Published: September 27, 2017 ABSTRACT The importance of interactions between the brain and the gastrointestinal tract has been increasingly recognized in recent years. It has been proposed that dysregulation and abnormalities in the brain-gut axis contribute to the etiology of a variety of central nervous system disorders. Particularly, dysbiosis, or impaired microbiota, has been implicated in multiple neurological and psychological disorders. The present paper reviews current evidence and theories concerning the possible mechanisms by which microbiota dysfunction contributes to the pathogenesis of schizophrenia and major depressive disorder. Clinical trials that investigated the possibility of treating both illnesses by correcting and rebalancing microbiota with probiotics are also reviewed. Overall, despite the accumulated knowledge in this field, more studies are warranted and required to further our understanding of the brain-gut axis and the possibility of targeting microbiota as a treatment option for schizophrenia and major depressive disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Principles and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342 · cited 1×
“The brain-gut axis conducts signaling between the brain and the gastrointestinal tract, which plays a fundamental role in normal physiological processes [1].”
BackgroundMessaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Rougeot, C., Pichelin, M., Cazaubiel, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510004319 · Cited by 1,324 · cited 2×
“, 2016 [69] MDD patients Double-blind, placebo-controlled Supplement probiotics vs placebo Significantly improved MDD symptoms”
BackgroundCorrelation between the human fecal microbiota and depression
Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R., & Rudi, K. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12378 · Cited by 1,044
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.009 · Cited by 952 · cited 1×
“Specifically, in an animal study, treatment with Bifidobacteria infantis resulted in a significant change in serotonin metabolism in the brain [44].”
ResultAkkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · cited 3×
“, 2017 [71] MDD patients Double-blind, randomized placebocontrolled Probiotics as a primary treatment No effect was noted in any of the psychological and functional assessments”
MethodResultInfluentialFröhlich, E. E., Farzi, A., Mayerhofer, R., Reichmann, F., Jačan, A., Wagner, B., Zinser, E., Bordag, N., Magnes, C., Fröhlich, E., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.020 · Cited by 720
The neurobiology of stress and gastrointestinal disease
MAYER, E. A. (2000) · Gut · doi:10.1136/gut.47.6.861 · Cited by 666 · cited 1×
“The brain modulates gut functions including motility, acid secretion, the production of bicarbonates as well as mucus, and the immune response via the autonomic nervous system (ANS), thereby inducing responses to stress in the gastrointestinal system [16].”
BackgroundPetra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Impact of consuming a milk drink containing a probiotic on mood and cognition
Benton, D., Williams, C., & Brown, A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602546 · Cited by 554
The gut microbiome in human neurological disease: A review
Tremlett, H., Bauer, K. C., Appel‐Cresswell, S., Finlay, B. B., & Waubant, E. (2017) · Annals of Neurology · doi:10.1002/ana.24901 · Cited by 535 · cited 1×
“In recent years, interactions between the brain and gut microbiota have been explored, as microbiota has been found to be an important player in the pathogenesis of various neurological diseases [8] including multiple sclerosis [9, 10], Alzheimer’s disease [11], and Parkinson’s disease [12].”
BackgroundAnalysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453 · cited 1×
“In schizophrenia patients, a decreased level of plasma BDNF has been noted, although findings from different studies have been inconsistent [28, 29].”
ResultNLRP6 Protects Il10 Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Seregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Pudlo, N. A., Mitchell, J., Baxter, N. T., Zhao, L., Schloss, P. D., Martens, E. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.080 · Cited by 386
Microbial biofilms in the human gastrointestinal tract
Macfarlane, S., & Dillon, J. F. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03287.x · Cited by 379 · cited 1×
“Particularly, the ANSmediated modulation of mucus secretion could alter the environments that the microbiota inhabits and profoundly affect its composition and structure [17].”
BackgroundSchwarz, E., Maukonen, J., Hyytiäinen, T., Kieseppä, T., Orešič, M., Sabunciyan, S., Mantere, O., Saarela, M., Yolken, R., & Suvisaari, J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.017 · Cited by 333 · cited 1×
“Further analyses indicated that increases in Lactobacillus group bacteria were significantly correlated with the severity of different symptom domains in schizophrenia patients [24].”
BackgroundRomijn, A. R., Rucklidge, J. J., Kuijer, R. G., & Frampton, C. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416686694 · Cited by 323
Labus, J. S., Hollister, E. B., Jacobs, J., Kirbach, K., Oezguen, N., Gupta, A., Acosta, J., Luna, R. A., Aagaard, K., Versalovic, J., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0260-z · Cited by 284 · cited 1×
“More recently, Labus et al described a correlation between gut microbial composition and regional brain volume in patients with irritable bowel syndrome [14].”
BackgroundSlyepchenko, A., Maes, M., Jacka, F. N., Köhler, C. A., Barichello, T., McIntyre, R. S., Berk, M., Grande, I., Foster, J. A., Vieta, E., et al. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448957 · Cited by 278
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Tourjman, V., Kouassi, É., Koué, M.-È., Rocchetti, M., Fortin-Fournier, S., Fusar-Poli, P., & Potvin, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.011 · Cited by 224
Chung, Y.-C., Jin, H.-M., Cui, Y., Kim, D. S., Jung, J. M., Park, J.-I., Jung, E.-S., Choi, E.-K., & Chae, S.-W. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.07.007 · Cited by 173 · cited 2×
“, 2017 [70] SSRI-resistant MDD patients Cohort study Combined supplement of probiotics and magnesium orotate, co-administered with an SSRI Significantly improved MDD symptoms, and relapse when patients ceased to take probiotics while on SSRI”
BackgroundMethodDickerson, F. B., Stallings, C., Origoni, A., Katsafanas, E., Savage, C. L. G., Schweinfurth, L. A. B., Goga, J., Khushalani, S., & Yolken, R. H. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13m01579 · Cited by 166 · cited 2×
“, 2017 [65] * Schizophrenia patients Longitudinal study Adjunctive probiotic vs placebo GI function improvement associated with a decrease in C.”
BackgroundSchizophrenia and the gut–brain axis
Nemani, K., Hosseini Ghomi, R., McCormick, B., & Fan, X. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.018 · Cited by 151 · cited 1×
“Schizophrenia is a serious psychiatric disorder, characterized by psychosis, in which the involvement of the gut-brain axis has long been recognized [20, 21].”
BackgroundKynurenine pathway in psychosis: evidence of increased tryptophan degradation
Barry, S., Clarke, G., Scully, P., & Dinan, T. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108089583 · Cited by 96 · cited 1×
“Although the exact role of the kynurenic pathway of tryptophan metabolism in the pathogenesis of schizophrenia has not been elucidated, some studies report that the upregulation of the pathway is associated with schizophrenia [47, 48].”
Background
Cited by
Zheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau8317 · Cited by 704
Probiotics and the microbiota-gut-brain axis: Focus on psychiatry
Mörkl, S., Butler, M. I., Holl, A., Cryan, J. F., & Dinan, T. G. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00313-5 · Cited by 337
Faecal short chain fatty acids profile is changed in Polish depressive women
Skonieczna-Żydecka, K., Grochans, E., Maciejewska, D., Szkup, M., Schneider-Matyka, D., Jurczak, A., Łoniewski, I., Kaczmarczyk, M., Marlicz, W., Czerwińska-Rogowska, M., et al. (2018) · Nutrients · doi:10.3390/nu10121939 · Cited by 284
Altered gut microbiota associated with symptom severity in schizophrenia
Li, S., Zhuo, M., Huang, X., Huang, Y., Zhou, J., Xiong, D., Li, J., Liu, Y., Pan, Z., Li, H., et al. (2020) · PeerJ · doi:10.7717/peerj.9574 · Cited by 142
“Some clinical studies indicate potential associations between a disturbed gut microbiome and SZ (Lv et al., 2017).”
Self-citationMitochondria could be a potential key mediator linking the intestinal microbiota to depression
Chen, J., & Vitetta, L. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29311 · Cited by 36
Metadata
- Authors
- Lv, F., Chen, S., Wang, L., Jiang, R., Tian, H., Li, J., Yao, Y., & Zhuo, C.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-09-27
- Volume
- 8
- Issue
- 59
- Pages
- 100899-100907
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2759966800
- Cited by
- 66
- References
- 28
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.